Member Info for crumbs

An American backer as in money arrived then that would have been different but they never ever did and haven't and seemingly won't either ... the SCIB1 combo elephant in the room that we could not shift for years has suddenly just when you thought it had been pushed out the window got back in via the letterbox... yeah the trial will go ahead-eventually but this setback is AIM shark chump... hopefully no delays on modi1 now and SCIB2 is got going ASAP

I wonder was the whole US direction thing simply because Chippers lives there.... well I know KF came and made himself willingly available which was/is seductive indeed ... but the trial ought to have been done and dusted years ago yet still we wait and very possibly modi1 trial will be on before any SCIB1 combo patients are even dosed... yeah let the BOD boys squirm I only take a little comfort in buying shares at this price knowing I'm getting them cheaper than Chippers and he is underwater now too... along with L&G and all our ii... whom I hope are applying pressure too..

no, and keep nibbling away to try and get as low an average and as many shares as possible for valuation day but AIM is not the most rational of markets ... a successful trial in sea of failures that has not been valued at all by AIM... it does seem more certain than ever that it will only be other bios and pharma that eventually give scancell an honest valuation

The sad thing is.... the company is so far from those days and yet the sp......

Were them the one packet of digestives days

What each member gets the same set amount of presentation time by law?

Hope someone records it and shares... it's usually botski who does a fine job and had a good rapport with RG seems botski is jaded with scancell at the moment though too (understandable) ... I have gained from all the AGM and other meeting/presentations so disagree that they are useless scancell usually give as much as they can out at these events and with 3 platforms there is so much info to give ... would prefer if more presentation time is given to LD though as the others mainly waffle and can't talk 8p up to 10p

Relate councillors attending

It would be strong hinting :)

Anyways really this AGM should not be a 2015 and infact that should never be repeated DE is gone the company is very different it has much lower sp and mcap for one thing lol... but what I mean is there really is a strategy now that has been clearly set out and I would expect pi to get a more in-depth explanation of the FDA issue...which is a non fatal issue the trial will go ahead just later... expect June 2019

Plenty of moditope progress hopefully news on SCIB2 and potential nano delivery and possibly a proper unveiling of the new platform with a sweet name attached and trials pencilled in for 2030

They turn up in Genentech T shirts and take notes with pens provided by Roche that might be good

Maybe they are legally unable to answer

Tea and biscuits are never wasted... if there is jam on the day on offer that would be nice too :)

I mean all of humanity

We just need to solve the scancell hold up:)

Nowhere on forthcoming CRUK SCIB2 combo trial information is Ichor mentioned only this nano approach ... so you could be right they will go with the Ichor but they have not said so... something that can be cleared up at AGM

Ahh yes it is... It's his device and it has sp affecting side effects :)

'Nano-vesicle delivery under evaluation'

http://www.oxfordtechnology.com/admin/jscripts/tiny_mce/plugins/filemanager/files/news/Scancell%20OTVCT%20AGM.pdf

page 10...

Also, the tests that were done with this delivery clearly show it improves the effect of SCIB2 on mice at least by quite a lot too!

Also I am thinking far ahead is when ImmunoBody is considered possibly as a preventative therapy as in those at risk are immunized by an ImmunoBody as to never even suffer the disease they are vulnerable too... I believe this is LD's vision as laid out in this article:

So, Professor Durrant explained, we need to do two things.

We need to provide some assistance to these late stage cancer drugs, but even more usefully we need to tackle cancer early on, before it has become aggressive.

Unwittingly carrying cancer
Many of us will harbour cancer cells without realising it. Indeed we may well die before it ever becomes a problem.

The average age at which cancer is diagnosed is roughly 70, meaning that the first cancerous cells would have appeared around the age of 50.

Ideally then, for the sake of our health but also to save some of the huge costs associated with late stage treatment, we would like to tame cancer before it gets subversive and aggressive.

The way to do this is with a vaccine.

In their early days, before they have developed too many mutations and turned aggressive, cancer cells will provoke an immune reaction and can be tamed by the body’s natural defences.

https://ukuncensored.com/what-i-learned-from-the-ceo-of-an-immunotherapy-start-up/

I do not mean on SCIB1 ... SCIB2 is already being looked at as the first candidate to move from electroporation and be trialed in combo using that delivery.. the reasons I would say are many but one that comes out from the lab already is it is more effective than electroporation perhaps there are less dose restrictions as in not stuck to 8mg... another thing will be price and another will be easy of administration and yet another patient comfort... so for me the nano route if it comes off is the way forward for ImmunoBody as a platform.. but sure for now SCIB1 has to go the elctro route ...it already proved itself to work

Ahh yeah, suppose in that context your right... really hope one day we can move away from that device though so hopefully someone will ask about nano delivery of ImmunoBody .to me its very key to the future of that platform and its commercial prospects...and where we are with that now at the AGM if they do not update on the day that is,who knows it might be a day all kinds of new info and plans for the glyco platform as in how close to possible trials is that tech? ...